Prospective clinical study to evaluate an active myofunctional therapy for the treatment of snoring and mild obstructive sleep apnea

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035101

Enrollment

120

Registered

2024-09-23

Start date

2021-03-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary snoring G47.31

Interventions

Group 1: Treatment group: orolingual myofunctional therapy modified according to Pongratz Probands are instructed in the orolingual exercises by a speech therapist. Then they perfom the exercises ind

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. signed informed consent, 2. age between 18 and 65 years, 3. history of snoring (>5 times a week for at least 6 months), 4. available bed partner for assessing snoring quality and quantity

Exclusion criteria

Exclusion criteria: 1. body mass index (BMI) > 35 kg/m², 2. ESS > 10, 3. AHI >15/h, 4. symptomatic nasal breathing obstruction or allergic rhinitis, 5. tonsils > grade 2 (Brodsky grading scale) or velum surgery, 6. relevant retrognathia, 7. pregnancy 8. neurodegenerative diseases

Design outcomes

Primary

Measure	Time frame
Total snoring score consisting of 3 visual analogue scales for frequency, duration and intensity of snoring	—

Secondary

Measure	Time frame
Home sleep test with Snoring Index, percentage snoring teime, apnea-hypopnea-Index; Epworth Sleepiness Scale; Pittsburgh Sleep Quality Index	—

Countries

Germany

Contacts

Public ContactPhilipp Schendzielorz

Universitätsklinikum Würzburg, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie

Schendziel_P@ukw.de0931-20121323

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026